Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “End-organ Damage”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableLooking for participantsNCT06837766
What this trial is testing

Study About Hepatic Toxins Kinetic and Evaluation of Organ Damage in Acute on Chronic Liver Failure (ACLF) Patients

Who this might be right for
Acute on Chronic Liver Failure (ACLF)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 40
Large-scale testing (Phase 3)WithdrawnNCT02684487
What this trial is testing

Vitamin D Status in Patients With Severe Sepsis

Who this might be right for
SepsisSevere SepsisEnd Organ Damage+1 more
Massachusetts General Hospital
Not applicableUnknownNCT04213963
What this trial is testing

Prospective Study on Primary Aldosteronism in Resistant Hypertension

Who this might be right for
Resistant HypertensionPrimary AldosteronismRefractory Hypertension+3 more
University of Turin, Italy 100
Not applicableEnded earlyNCT00428571
What this trial is testing

Laparoscopic Bariatric Surgery to Treat Type 2 Diabetes in Obese Patients

Who this might be right for
Type 2 Diabetes
Hamilton Health Sciences Corporation 20
Large-scale testing (Phase 3)Enrolling By InvitationNCT05101746
What this trial is testing

Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass

Who this might be right for
Congenital Heart DiseaseCongenital Heart DefectCongenital Heart Malformations
Vanderbilt University Medical Center 50
Post-approval studies (Phase 4)Study completedNCT01872039
What this trial is testing

Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients

Who this might be right for
Hypertension EmergencyEnd-organ Damage
Astellas Pharma China, Inc. 163
Not applicableStudy completedNCT02444689
What this trial is testing

EMPower: Electronic Media Powering Positive Health Changes in Youth

Who this might be right for
HypertensionPrehypertensionOverweight+2 more
Johns Hopkins University 91